Dapsone-Trimethoprim for Pneumonia in the Acquired Immunodeficiency Syndrome

Leoung, Clifford S.; Mills, John; Hopewell, Philip C.; Hughes, Walter; Wofsy, Constance
July 1986
Annals of Internal Medicine;Jul86, Vol. 105 Issue 1, p45
Academic Journal
Presents a study that examined the efficacy of dapsone plus trimethoprim for the treatment of patients with AIDS and a first episode of Pneumocystis carinii pneumonia. Methodology; Characteristics of patients with AIDS and Pneumocystis carinii pneumonia treated with dapsone-trimethoprim; Results and discussion.


Related Articles

  • Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective randomized trial. Wharton, J. Marcus; Coleman, Diana Lewis; Wofsy, Constance B.; Luce, John M.; Blumenfeld, Walter; Hadley, W. Keith; Ingram-Drake, Leslie; Volberding, Paul A.; Hopewell, Philip C.; Wharton, J M; Coleman, D L; Wofsy, C B; Luce, J M; Blumenfeld, W; Hadley, W K; Ingram-Drake, L; Volberding, P A; Hopewell, P C // Annals of Internal Medicine;Jul86, Vol. 105 Issue 1, p37 

    Forty patients with the acquired immunodeficiency syndrome (AIDS) and their first episodes of Pneumocystis carinii pneumonia were assigned at random to receive either trimethoprim-sulfamethoxazole or pentamidine isethionate. The two groups did not differ significantly in the severity of...

  • Clinical efficacy of first- and second-line treatments for HIV-associated Pneumocystis jirovecii pneumonia: a tri-centre cohort study. Helweg-Larsen, Jannik; Benfield, Thomas; Atzori, Chiara; Miller, Robert F. // Journal of Antimicrobial Chemotherapy (JAC);Dec2009, Vol. 64 Issue 6, p1282 

    Objectives: First-line therapy for Pneumocystis jirovecii pneumonia (PCP) is trimethoprim/sulfamethoxazole. Few data exist to guide the choice of second-line therapy for patients failing or developing toxicity to first-line therapy.

  • Trimethoprim-sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective, noncrossover study. Sattler, Fred R.; Cowan, Robert; Nielsen, Donald M.; Ruskin, Joel; Sattler, F R; Cowan, R; Nielsen, D M; Ruskin, J // Annals of Internal Medicine;8/15/88, Vol. 109 Issue 4, p280 

    Study Objective: To ascertain the efficacy and toxicity of trimethoprim-sulfamethoxazole or pentamidine when either is given alone during the entire treatment period for Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome (AIDS).Design:...

  • Improved Treatment For Pneumocystis. Helquist, Michael // Advocate;10/13/87, Issue 483, p23 

    Reports on the efficacy of aerosol pentamidine against pneumocystis carinii pneumonia in persons with AIDS. Absence of side effects; Reduction in average hospital stay.

  • DELAYING THE ONSET OF ILLNESS. Cohan, Gary R. // Advocate;2/8/94, Issue 648, p34 

    Reports that prophylaxis against Pneumocystis carinnii infection may delay the onset of the first AIDS-related illness.

  • FDA Grants Initial OK To AIDS Drug. Harding, Rick // Advocate;3/14/89, Issue 520, p14 

    Reports that the United States Food and Drug Administration (FDA) approved the use of an aerosol form of the drug, pentamidine to fight Pneumocystis carinii pneumonia associated with AIDS deaths. Properties of the product; Recommendations for further trials.

  • Clindamycin/tacrolimus interaction.  // Reactions Weekly;10/2/2010, Issue 1321, p14 

    The article describes the case of a woman who experienced decreased serum tacrolimus concentrations after starting clindamycin to treat Pneumocystis carinii (P. jirovecii) pneumonia.

  • Dapsone.  // Reactions Weekly;9/16/2006, Issue 1119, p11 

    The article focuses on a case report involving the effect of the drug dapsone in treating Pneumocystis carinii pneumonia in a child. Dapsone was administered to an 11-year-old boy with a history of chronic immune thrombocytopenic purpura. Within 24 hours, the patient had blue lips. Two days...

  • Clindamycin-primaquine versus pentamidine for the second-line treatment of pneumocystis pneumonia. Tark Kim; Sung-Han Kim; Ki-Ho Park; Oh Cho; Heungsup Sung; Mi-Na Kim; Sang-Ho Choi; Jin-Yong Jeong; Jun Woo; Yang Kim; Sang-Oh Lee // Journal of Infection & Chemotherapy (Springer Science & Business;Oct2009, Vol. 15 Issue 5, p343 

    Abstract  There are limited data on the efficacy of alternative regimens for treating patients with pneumocystis pneumonia (PCP). We compared the efficacy of clindamycin-primaquine (C-P) with that of pentamidine as a secondline treatment for PCP. Among 91 patients receiving...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics